Healthcare Expansion

Charleston, SC – – September 29, 2026 -- Solis Mammography has formed a joint venture with HCA Healthcare Trident Hospital, marking the company's first entry into South Carolina and its 26th major market nationwide.

Trident Hospital's breast imaging unit rebrands under the Solis name

The partnership converts Trident Hospital's existing breast imaging services into Solis Mammography, a department of HCA Healthcare Trident Hospital, located at 9313 Medical Plaza Dr., Suite 201, Charleston. The companies plan to expand the model into additional HCA Healthcare facilities across the greater Charleston area.

McDonough, Ga. – September 22, 2026 -- Piedmont Orthopedics | OrthoAtlanta has added board-certified interventional pain specialist Vic Manocha, M.D., to its Henry County team, deploying him across both its McDonough office and its newly opened Locust Grove location.

New physician strengthens nonsurgical pain treatment capacity

Dr. Manocha treats acute and chronic back pain, neck pain, joint pain and musculoskeletal conditions using interventional techniques including spinal cord stimulation, peripheral nerve stimulation and minimally invasive spine procedures. He also maintains a focus on regenerative medicine and orthobiologic therapies for chronic spine and joint pain, and is the founder of RegenCures, a practice dedicated to orthobiologic treatments.

Grand Rapids – September 15, 2026 -- Headlands Research has established a new clinical trial site in Grand Rapids, Michigan, led by board-certified rheumatologist Eric Slavin, MD, FACP, FACR, expanding the network's capacity for rheumatology, autoimmune disease, and cardiometabolic trials in the Midwest.

New de novo site targets high-demand therapeutic areas

Headlands Research - Grand Rapids is currently under development and expected to open later in 2026. The site will focus on rheumatology, bone and joint conditions, and autoimmune and inflammatory diseases, while also conducting studies in general medicine, chronic kidney disease, obesity, hypertension, hyperlipidemia, and vaccines.

Kyle Burtnett, CEO of Headlands Research, said sponsor demand for rheumatology and autoimmune disease trials continues to climb, positioning the new site to address that gap in the Midwest market.